I like to nominate that Biota will get $45m for the 3 months. My reasoning is that although GSK said it had 5m Relenza stock in May, April had huge orders which would have been filled from their stockpile so here is my guess:
April 15m (the months manufacture plus extra stock from birdflu scare)
May 5m stock plus 5m manufactured = 10m
June 5m
So 25*1.8 = $45m
Remember this is my guess.
If true or close to it and the forward sales into northern winter BTA should be a good price tommorrow
Add to My Watchlist
What is My Watchlist?